Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 10,285,308
- Share change
- +507,419
- Total reported value
- $77,138,000
- Price per share
- $7.50
- Number of holders
- 42
- Value change
- +$3,821,299
- Number of buys
- 29
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.2%
|
3,085,458
|
$20,981,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
2.7%
|
1,611,311
|
$10,957,000 | — | 31 Dec 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.7%
|
1,044,131
|
$7,100,000 | — | 31 Dec 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.5%
|
915,000
|
$6,222,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
715,679
|
$4,867,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
698,534
|
$4,750,000 | — | 31 Dec 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
693,000
|
$4,712,000 | — | 31 Dec 2017 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.27%
|
164,384
|
$1,118,000 | — | 31 Dec 2017 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.21%
|
124,096
|
$844,000 | — | 31 Dec 2017 | |
| Hikari Power Ltd |
13F
|
Company |
0.18%
|
107,858
|
$733,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
102,263
|
$695,000 | — | 31 Dec 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
62,100
|
$422,000 | — | 31 Dec 2017 | |
| WOODSTOCK CORP |
13F
|
Company |
0.1%
|
58,243
|
$396,000 | — | 31 Dec 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
50,923
|
$346,000 | — | 31 Dec 2017 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.08%
|
50,000
|
$340,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
49,676
|
$338,000 | — | 31 Dec 2017 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.08%
|
45,000
|
$306,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
37,694
|
$256,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
35,861
|
$244,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
22,669
|
$155,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
18,378
|
$125,000 | — | 31 Dec 2017 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.03%
|
16,250
|
$111,000 | — | 31 Dec 2017 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.02%
|
14,287
|
$95,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
13,540
|
$92,000 | — | 31 Dec 2017 | |
| DRW Securities, LLC |
13F
|
Company |
0.02%
|
12,000
|
$82,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
10,110
|
$69,000 | — | 31 Dec 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
5,534
|
$38,000 | — | 31 Dec 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
3,500
|
$24,000 | — | 31 Dec 2017 | |
| AlphaOne Investment Services, LLC |
13F
|
Company |
0%
|
2,375
|
$16,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,925
|
$13,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
1,700
|
$11,000 | — | 31 Dec 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
1,400
|
$10,000 | — | 31 Dec 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,353
|
$9,000 | — | 31 Dec 2017 | |
| Private Ocean, LLC |
13F
|
Company |
0%
|
1,000
|
$7,000 | — | 31 Dec 2017 | |
| PEDDOCK CAPITAL ADVISORS, LLC |
13F
|
Company |
0%
|
752
|
$5,000 | — | 31 Dec 2017 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
250
|
$1,000 | — | 31 Dec 2017 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q1 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.